Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

404
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

530
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

337
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
337
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

484
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
484
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

526
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
526
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

573
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
573

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Giornale Italiano di Cardiologia: impact factor and impact to readers].

Giornale italiano di cardiologia (2006)·2026
Same author

[Presentation].

Giornale italiano di cardiologia (2006)·2026
Same author

[Giornale Italiano di Cardiologia and artificial intelligence].

Giornale italiano di cardiologia (2006)·2026
Same author

[The non-ST-elevation myocardial infarction network in Italy: still an unmet need].

Giornale italiano di cardiologia (2006)·2026
Same author

Giornale italiano di cardiologia (2006)·2026
Same author

[Presentation].

Giornale italiano di cardiologia (2006)·2026

Related Experiment Video

Updated: Mar 11, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K

Severe low-gradient aortic stenosis, with preserved ventricular function: should it be treated?

Giuseppe Di Pasquale1, Gloria Vassilikì Coutsoumbas, Silvia Zagnoni

  • 1Cardiology Unit, Maggiore Hospital, Bologna, Italy.

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|November 23, 2016
PubMed
Summary
This summary is machine-generated.

Severe paradoxical aortic stenosis (SAO) with low flow and low gradient (LFLG) is linked to higher mortality. Accurate diagnosis, distinguishing it from other aortic stenosis forms, is crucial for appropriate treatment and improved patient outcomes.

More Related Videos

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.8K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.8K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiac Imaging

Background:

  • Severe paradoxical aortic stenosis (SAO) with low flow and low gradient (LFLG) affects patients with small aortic valve area and normal ejection fraction.
  • This condition is associated with increased mortality, regardless of medical or surgical management.

Purpose of the Study:

  • To emphasize the critical importance of correctly defining diagnostic criteria for SAO LFLG.
  • To highlight the need for accurate flow measurement in differentiating SAO LFLG from other forms of aortic stenosis.

Main Methods:

  • Review of diagnostic criteria for paradoxical aortic stenosis.
  • Consideration of Multidetector Computed Tomography (MDCT) for aortic valve calcification quantification.
  • Emphasis on echocardiographic assessment of flow and gradient.

Main Results:

  • Accurate differentiation of SAO LFLG from other aortic stenosis types is diagnostically challenging.
  • MDCT can aid in quantifying aortic valve calcifications when diagnosis is uncertain.
  • Guidelines recommend aortic valve replacement for symptomatic patients with SAO LFLG.

Conclusions:

  • Correctly identifying SAO LFLG is essential for guiding therapeutic decisions.
  • Accurate flow assessment is key to distinguishing SAO LFLG and informing prognosis.
  • Further research may refine diagnostic and management strategies for this specific patient group.